Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Cytek Biosciences, Inc. - Common Stock (CTKB)

6.1200
-0.2000 (-3.16%)
NASDAQ · Last Trade: Nov 22nd, 9:04 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcriptfool.com
China weakness and litigation costs weighed on the quarter's results.
Via The Motley Fool · November 5, 2026
Cytek Biosciences Q3 Earnings Call Highlightsmarketbeat.com
Cytek Biosciences (NASDAQ:CTKB) reported third-quarter 2026 revenue of $53.2 million, up 2% from a year earlier, as growth in the U.S. and demand for its high-end instruments helped offset weakness in Asia-Pacific. The flow cytometry company narrowed its full-year revenue guidance to $208 million t
Via MarketBeat · November 4, 2026
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Via Chartmill · September 23, 2026
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earningschartmill.com
Via Chartmill · February 26, 2026
Earnings Scheduled For November 5, 2025benzinga.com
Via Benzinga · November 5, 2025
Earnings Scheduled For August 6, 2025benzinga.com
Via Benzinga · August 6, 2025
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stockbenzinga.com
Via Benzinga · May 28, 2025
Earnings Scheduled For May 8, 2025benzinga.com
Via Benzinga · May 8, 2025
Earnings Scheduled For February 27, 2025benzinga.com
Via Benzinga · February 27, 2025
Cytek (CTKB) Q2 2026 Earnings Call Transcriptfool.com
U.S. revenue surged 18% while EMEA declined 8% amid geopolitical pressures.
Via The Motley Fool · August 12, 2026
Cytek Biosciences Q2 Earnings Call Highlightsmarketbeat.com
Cytek Biosciences (NASDAQ:CTKB) reported second-quarter 2026 revenue growth of 6% year over year, supported by double-digit gains in the United States and China, while continued weakness in Europe and parts of Asia-Pacific limited overall growth. Revenue for the quarter ended June 30 was $48.1 mill
Via MarketBeat · August 5, 2026
Cytek (CTKB) Q1 2026 Earnings Call Transcriptfool.com
Cytek (CTKB) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 8, 2026
Preview: Cytek Biosciences's Earningsbenzinga.com
Via Benzinga · November 4, 2024
Cytek (CTKB) Q4 2025 Earnings Call Transcriptfool.com
Cytek (CTKB) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 27, 2026
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · November 14, 2025
Cytek (CTKB) Q3 2025 Earnings Call Transcriptfool.com
Cytek (CTKB) Q3 2025 Earnings Call Transcript
Via The Motley Fool · November 5, 2025
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 28, 2025
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In Novemberbenzinga.com
Via Benzinga · December 30, 2024
Crude Oil Gains 1%; Chicago PMI Falls In Decemberbenzinga.com
Via Benzinga · December 30, 2024
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · December 30, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 19, 2024
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Viewsbenzinga.com
Via Benzinga · November 6, 2024
Gold Down Over 2%; CVS Health Shares Jump After Q3 Resultsbenzinga.com
Via Benzinga · November 6, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · November 6, 2024
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · November 6, 2024